Diabetes Management Software Market

Diabetes Management Software Market Forecast and Outlook 2025 to 2035

The diabetes management software market stands at the threshold of a decade-long expansion trajectory that promises to reshape digital health technology and chronic disease management solutions. The market's journey from USD 2.7 billion in 2025 to USD 8.5 billion by 2035 represents substantial growth, the market will rise at a CAGR of 12.2% which demonstrating the accelerating adoption of advanced digital health technology and diabetes care optimization across healthcare facilities, medical device integration, and global digital health markets.

The first half of the decade (2025-2030) will witness the market climbing from USD 2.7 billion to approximately USD 4.8 billion, adding USD 2.1 billion in value, which constitutes 41% of the total forecast growth period. This phase will be characterized by the rapid adoption of cloud-based systems, driven by increasing remote monitoring demands and the growing need for connected diabetes care solutions worldwide. Enhanced CGM integration capabilities and real-time data analysis systems will become standard expectations rather than premium options.

The latter half (2030-2035) will witness continued growth from USD 4.8 billion to USD 8.5 billion, representing an addition of USD 3.7 billion or 59% of the decade's expansion. This period will be defined by mass market penetration of AI-powered analytics platforms, integration with comprehensive digital health ecosystems, and seamless compatibility with existing healthcare infrastructure. The market trajectory signals fundamental shifts in how healthcare providers approach diabetes care optimization and patient engagement management, with participants positioned to benefit from growing demand across multiple deployment types and user segments.

Quick Stats for Diabetes Management Software Market

• Diabetes Management Software Market Value (2025): USD 2.7 billion
• Diabetes Management Software Market Forecast Value (2035): USD 8.5 billion
• Diabetes Management Software Market Forecast CAGR: 12.2%
• Leading Deployment Type in Diabetes Management Software Market: Cloud/SaaS
• Key Growth Regions in Diabetes Management Software Market: North America, Western Europe, and East Asia
• Top Key Players in Diabetes Management Software Market: Dexcom, Abbott, Medtronic, Roche, Ascensia
• Where revenue comes from - now vs next (industry-level view)

Period	Primary Revenue Buckets	Share	Notes
Today	Cloud/SaaS platforms	63%	Remote access and scalability focus
	On-premise installations	37%	Healthcare facility-based systems
	CGM-linked integrations	51%	Continuous glucose monitoring connectivity
	Patient direct applications	56%	Consumer and patient-facing solutions
Future (3-5 yrs)	AI-powered analytics platforms	70-75%	Predictive insights and personalized recommendations
	Integrated care ecosystems	60-65%	Multi-device and multi-stakeholder platforms
	Telehealth integration	25-30%	Remote consultation and monitoring capabilities
	Provider-focused solutions	35-40%	Healthcare professional tools and clinical decision support
	Real-time coaching systems	20-25%	Behavioral change and lifestyle management

Diabetes Management Software Market Key Takeaways

At-a-Glance Metrics

Metric	Value
Market Value (2025) →	USD 2.7 billion
Market Forecast (2035) ↑	USD 8.5 billion
Growth Rate ★	12.2% CAGR
Leading Deployment Type →	Cloud/SaaS
Primary End User →	Patients

The market demonstrates exceptional fundamentals with cloud/SaaS platforms capturing a dominant 63% share through scalable deployment capabilities and remote access optimization. Patient-focused applications drive primary demand at 56%, supported by increasing diabetes prevalence and consumer preferences for personalized diabetes management solutions. Geographic expansion remains concentrated in developed markets with established digital health infrastructure, while emerging economies show accelerating adoption rates driven by chronic disease burden and healthcare digitization initiatives.

Imperatives for Stakeholders in Diabetes Management Software Market

Design for patient outcomes, not just data collection

• Offer comprehensive care packages: software platforms + device integration + clinical support + patient education + outcome tracking systems.
• Preconfigured care workflows: glucose monitoring, medication management, lifestyle tracking, and clinical communication systems.

Interoperability readiness

• Multi-device connectivity, EHR integration, and seamless data exchange with healthcare provider systems and medical device ecosystems.

Clinical validation-by-default

• Evidence-based algorithms, clinical outcome studies, regulatory compliance, and comprehensive safety validation with healthcare professional endorsement.

Patient engagement without complexity

• Intuitive user interfaces + personalized insights; behavioral change support and motivational features with gamification elements.

Segmental Analysis

Primary Classification: The market segments by deployment into cloud/SaaS and on-premise categories, representing the evolution from facility-based systems to scalable cloud-based diabetes management platforms for diverse healthcare optimization.

Secondary Classification: Device integration segmentation divides the market into CGM-linked, insulin pump-linked, and apps/manual entry sectors, reflecting distinct requirements for continuous monitoring, automated delivery, and user-input data management standards.

Tertiary Classification: End user segmentation covers patients, providers, and payers/others applications, while healthcare areas span self-management, clinical decision support, population health management, and remote monitoring programs.

Regional Classification: Geographic distribution covers North America, Western Europe, East Asia, and emerging markets, with developed regions leading adoption while developing economies show accelerating growth patterns driven by diabetes prevalence programs and digital health infrastructure expansion.

The segmentation structure reveals platform evolution from basic data collection toward comprehensive diabetes care ecosystems with enhanced clinical integration and patient engagement capabilities, while application diversity spans from individual self-management to healthcare system-wide diabetes program management requiring precise clinical decision support and population health solutions.

By Deployment, the Cloud/SaaS Segment Accounts for Dominant Market Share

Market Position: Cloud and SaaS platforms command the leading position in the diabetes management software market with 63% market share through scalable deployment features, including remote accessibility, automatic updates, and healthcare integration optimization that enable healthcare providers to achieve optimal diabetes care delivery across diverse clinical and patient care environments.

Value Drivers: The segment benefits from healthcare provider preference for flexible software systems that provide consistent patient data access, reduced IT infrastructure requirements, and care delivery optimization without requiring significant technical infrastructure investments. Advanced cloud features enable real-time data synchronization, multi-device access, and integration with existing healthcare systems, where accessibility performance and scalability represent critical healthcare technology requirements.

Competitive Advantages: Cloud/SaaS platforms differentiate through proven scalability profiles, consistent data accessibility characteristics, and integration with comprehensive healthcare systems that enhance clinical effectiveness while maintaining optimal security standards suitable for diverse patient care and clinical management applications.

Key market characteristics:

• Advanced deployment designs with optimized cloud architecture and healthcare integration capabilities
• Superior accessibility effectiveness, enabling 24/7 data access with consistent performance across devices
• Healthcare compatibility, including HIPAA compliance, security protocols, and clinical system integration for diabetes care applications

On-Premise Shows Healthcare Facility Growth

On-premise software installations maintain a 37% market position in the diabetes management software market due to their specialized security properties and institutional control advantages. These systems appeal to healthcare facilities requiring direct data control with competitive performance for large healthcare system applications. Market growth is driven by healthcare security expansion, emphasizing data sovereignty solutions and institutional management through facility-based software systems.

By Device Integration, the CGM-linked Segment Shows Technology Leadership

Market Context: CGM-linked integrations demonstrate technology leadership in the diabetes management software market with 51% share due to widespread adoption of continuous glucose monitoring and increasing focus on real-time data collection, automated monitoring, and clinical decision support applications that maximize care effectiveness while maintaining patient convenience standards.

Appeal Factors: CGM integration operators prioritize data accuracy, real-time monitoring capability, and integration with existing diabetes care infrastructure that enables coordinated care delivery across multiple clinical and patient programs. The segment benefits from substantial medical device investment and diabetes technology programs that emphasize the acquisition of advanced monitoring systems for care optimization and clinical decision support applications.

Growth Drivers: Diabetes care programs incorporate CGM integration as standard components for patient monitoring, while diabetes technology advancement growth increases demand for continuous monitoring capabilities that comply with clinical standards and minimize care complexity.

Market Challenges: Varying device compatibility and integration standards may limit platform standardization across different medical device manufacturers or healthcare systems.

Technology dynamics include:

• Strong growth in continuous monitoring requiring advanced integration capabilities
• Increasing adoption in automated insulin delivery applications and closed-loop systems
• Rising integration with clinical decision support systems for care optimization and treatment adjustment assurance

Insulin Pump-linked Applications Maintain Automated Delivery Demand

Insulin pump-linked integrations capture 29% market share through specialized automated delivery requirements in insulin-dependent diabetes management, closed-loop systems, and advanced diabetes technology programs. These applications demand reliable pump communication systems capable of automated insulin adjustment while providing effective diabetes management and safety optimization.

Apps/Manual Entry Applications Show Accessibility Growth

Apps and manual entry systems account for 20% market share, including smartphone applications, basic data entry programs, and simplified diabetes tracking requiring accessibility capabilities for broader patient population optimization and basic diabetes management.

By End User, the Patients Segment Leads Healthcare Engagement

Market Position: Patient-focused applications command 56% market position with strong growth through optimal self-management approach that balances clinical effectiveness and user engagement for diverse diabetes care requirements.

Value Drivers: This end user segment provides the ideal combination of personal empowerment and clinical support, meeting requirements for self-monitoring, lifestyle management, and healthcare provider communication without excessive complexity or clinical barriers.

Growth Characteristics: The segment benefits from broad patient applicability across diabetes types, established self-care protocols, and comprehensive patient education that support widespread platform adoption and diabetes management success.

What are the Drivers, Restraints, and Key Trends of the Diabetes Management Software Market?

Category	Factor	Impact	Why It Matters
Driver	Diabetes prevalence growth & chronic disease burden	★★★★★	Rising diabetes rates globally drive demand for digital management tools and remote monitoring solutions
Driver	CGM technology advancement & device integration	★★★★★	Continuous glucose monitors enable real-time data collection; integration creates comprehensive care platforms
Driver	Telehealth adoption & remote care delivery	★★★★☆	COVID-19 accelerated telehealth; diabetes management software enables remote patient monitoring
Restraint	Data privacy concerns & regulatory compliance	★★★★☆	Healthcare data sensitivity requires robust security; regulatory requirements increase development costs
Restraint	Integration complexity & interoperability challenges	★★★☆☆	Multiple device types and healthcare systems create technical integration challenges
Trend	AI-powered insights & predictive analytics	★★★★★	Machine learning algorithms provide personalized recommendations and predict glucose trends
Trend	Patient engagement gamification & behavioral change	★★★★☆	Gamified interfaces and behavioral psychology improve patient adherence and lifestyle management

Analysis of the Diabetes Management Software Market by Key Country

The diabetes management software market demonstrates varied regional dynamics with Growth Leaders including USA (12.9% growth rate) and Mexico (12.5% growth rate) driving expansion through digital health initiatives and chronic disease management modernization. Strong Performers encompass Germany (11.8% growth rate), France (11.6% growth rate), and developed regions, benefiting from established healthcare systems and digital health technology adoption. Healthcare-Innovation Markets feature UK (11.5% growth rate) and Japan (11.3% growth rate), where medical technology expertise and healthcare digitization support robust growth patterns.

Regional synthesis reveals North American markets leading adoption through digital health innovation and diabetes care advancement programs, while European countries maintain strong growth supported by healthcare digitization initiatives and chronic disease management programs. Asian markets show robust growth driven by diabetes burden and healthcare technology adoption trends.

Region/Country	2025-2035 Growth	How to win	What to watch out
USA	12.9%	Lead with innovation & integration	Privacy regulations; reimbursement challenges
Germany	11.8%	Focus on clinical validation	Data protection laws; integration complexity
UK	11.5%	Leverage NHS digital strategy	Budget constraints; system integration
France	11.6%	Emphasize clinical outcomes	Regulatory requirements; physician adoption
Japan	11.3%	Develop aging population solutions	Conservative adoption; technology preferences
South Korea	11.5%	Build digital health ecosystem	Competition intensity; regulatory approval
Mexico	12.5%	Expand accessibility programs	Infrastructure limitations; affordability challenges

USA Drives Market Leadership

USA establishes market leadership through comprehensive digital health programs and advanced diabetes technology development, integrating diabetes management software as standard components in healthcare systems and chronic disease management installations. The country's 12.9% growth rate reflects healthcare technology sophistication and diabetes care innovation programs that mandate the availability of advanced digital health platforms in clinical and patient care facilities. Growth concentrates in major healthcare technology centers, including California, Massachusetts, and Texas, where digital health development showcases integrated diabetes care systems that appeal to healthcare providers seeking advanced patient management capabilities and clinical decision support applications.

American healthcare technology companies are developing sophisticated diabetes management solutions that combine domestic innovation advantages with advanced clinical features, including AI-powered analytics and enhanced patient engagement technologies. Distribution channels through healthcare systems and digital health platforms expand market access, while clinical adoption supports utilization across diverse diabetes care segments and patient populations.

Strategic Market Indicators:

• Healthcare facilities leading adoption with 82% utilization rate in endocrinology and primary care sectors
• Diabetes care programs providing substantial market demand for advanced digital health technology advancement
• Local healthcare technology companies capturing 65% market share through innovation leadership and comprehensive clinical offerings
• Export market development for digital health solutions targeting international healthcare markets

United Kingdom Shows NHS Digital Strategy Excellence

United Kingdom demonstrates market strength through NHS digital strategy programs and healthcare digitization initiatives, maintaining an 11.5% growth rate supported by national healthcare system integration and chronic disease management programs. The country leverages its established NHS infrastructure and digital health strategy to drive diabetes management software adoption across primary care and specialist diabetes services. Major healthcare regions in England, Scotland, and Wales showcase advanced digital health capabilities that integrate with comprehensive NHS services and patient care programs.

British market dynamics focus on evidence-based diabetes management software that balance clinical effectiveness with NHS cost-efficiency requirements important to UK healthcare providers and diabetes specialists. The market benefits from NHS digital initiatives supporting healthcare technology advancement and clinical partnerships that create constant demand for clinically validated diabetes management platforms in NHS and private healthcare applications.

Market Intelligence Brief:

• NHS digital integration and healthcare services leading growth with emphasis on clinical effectiveness and patient outcome optimization programs
• Healthcare system partnerships driving evidence-based platform adoption and diabetes care improvement programs
• Government digital health initiatives supporting healthcare technology accessibility and clinical excellence programs
• Brexit considerations influencing healthcare technology supply chains and European regulatory alignment strategies

Germany Emerges as Clinical Validation Leader

In Berlin, Munich, and Hamburg, healthcare facilities and diabetes centers are implementing clinically validated diabetes management software as standard components for patient care and clinical decision support applications, driven by increasing healthcare digitization initiatives and clinical excellence programs that emphasize the importance of evidence-based care capabilities. The market holds an 11.8% growth rate, supported by healthcare quality initiatives and digital health development programs that promote validated software systems for healthcare and clinical facilities. German healthcare providers are adopting diabetes platforms that provide consistent clinical performance and evidence-based features, particularly appealing in regions where clinical validation and patient safety represent critical healthcare requirements.

Market expansion benefits from established healthcare digitization infrastructure capabilities and international healthcare technology partnerships that enable domestic integration of validated diabetes management systems for patient care and clinical applications. Healthcare adoption follows patterns established in digital health management, where clinical evidence and outcome optimization drive platform selection decisions and clinical deployment.

Market Intelligence Brief:

• Healthcare digitization quality and clinical excellence segments driving adoption with 75% annual growth in validated platform utilization
• Clinical validation programs emphasizing diabetes software for evidence-based care and patient outcome improvement
• Local healthcare companies partnering with international providers for clinical validation technology integration
• Healthcare facilities implementing premium validated systems for patient care optimization and clinical management

France Maintains Clinical Excellence Position

The diabetes management software market in France demonstrates sophisticated healthcare capabilities with documented effectiveness in clinical applications through integration with existing healthcare systems and medical infrastructure. The country leverages medical expertise and healthcare system integration to maintain an 11.6% growth rate. Healthcare centers, including Île-de-France, Rhône-Alpes, and Provence-Alpes-Côte d'Azur, showcase premium installations where diabetes software integrate with comprehensive healthcare platforms and clinical management systems to optimize patient care operations and clinical effectiveness.

French healthcare companies prioritize clinical innovation and EU regulatory compliance in diabetes software development, creating demand for advanced systems with sophisticated features, including healthcare integration and clinical outcome optimization systems. The market benefits from established healthcare infrastructure and investment in digital health advancement that provides long-term patient benefits and compliance with international medical standards.

Strategic Market Considerations:

• Innovation focus on EU healthcare standardization and clinical excellence, driving premium platform segment growth
• Healthcare partnerships providing enhanced clinical capabilities and faster provider adoption cycles
• Technology collaboration between French companies and international healthcare organizations
• Clinical training programs expanding diabetes software integration in healthcare scenarios

Japan Shows Aging Population Focus

The diabetes management software market expansion in Japan benefits from aging population healthcare demand, including advanced diabetes management in Tokyo and Osaka, healthcare facility modernization, and medical technology programs that increasingly incorporate diabetes management software for chronic disease care optimization applications. The country maintains an 11.3% growth rate, driven by healthcare technology advancement and increasing recognition of digital diabetes care benefits, including patient monitoring and comprehensive disease management enhancement.

Market dynamics focus on patient-centered healthcare solutions that balance clinical effectiveness with usability considerations important to Japanese healthcare providers and elderly patients. Growing healthcare technology integration creates continued demand for sophisticated diabetes management platforms in medical infrastructure and chronic care modernization projects.

Market Intelligence Brief:

• Healthcare technology and chronic care segments leading growth with focus on aging population solutions and patient care optimization applications
• Regional healthcare requirements driving diverse platform portfolio from basic diabetes tracking to comprehensive care management systems
• Technology advancement emphasis on user experience and clinical integration systems
• Government healthcare initiatives supporting domestic medical technology capabilities and aging care competitiveness

South Korea Drives Digital Health Innovation

South Korea establishes strong market position through digital health innovation programs and healthcare technology advancement expansion, integrating advanced diabetes management software as standard components for patient care and healthcare system optimization applications. The country's 11.5% growth rate reflects government healthcare technology initiatives and medical digitization programs that emphasize advanced diabetes care systems for patient enhancement and healthcare optimization. Growth concentrates in major healthcare technology centers, including Seoul and Busan, where medical development showcases integrated diabetes management systems that appeal to healthcare providers seeking comprehensive patient care capabilities and clinical optimization applications.

Korean healthcare technology companies are developing innovative diabetes management solutions that combine domestic digital innovation advantages with advanced clinical features, including healthcare system integration and enhanced patient engagement capabilities. Distribution channels through healthcare technology suppliers and medical service providers expand market access, while government support for healthcare innovation supports adoption across patient care and medical segments.

Strategic Market Indicators:

• Healthcare technology innovation facilities leading adoption with 78% deployment rate in hospital and clinic sectors
• Government healthcare programs providing substantial funding for domestic medical technology advancement
• Local healthcare technology companies capturing significant market share through innovation leadership and healthcare integration expertise
• Export market development for advanced diabetes solutions targeting regional healthcare markets

Mexico Shows Healthcare Digitization Expansion

Market expansion in Mexico benefits from growing healthcare digitization, including medical system development in Mexico City and Guadalajara, healthcare facility upgrades, and chronic disease programs that increasingly incorporate diabetes management software solutions for patient care optimization applications. The country maintains a 12.5% growth rate, driven by healthcare digitization industry growth and increasing adoption of advanced medical technology solutions, including sophisticated diabetes care platforms and patient management enhancement.

Market dynamics focus on accessible diabetes management solutions that balance clinical effectiveness with affordability considerations important to Mexican healthcare providers and patients. Growing healthcare digitization creates continued demand for reliable diabetes management platforms in healthcare expansion and patient care improvement projects.

Strategic Market Considerations:

• Healthcare digitization expansion segments leading growth with focus on accessibility and patient care optimization applications
• Regional healthcare requirements driving diverse platform portfolio from basic diabetes tracking to comprehensive care management systems
• Import considerations balanced by potential domestic healthcare partnerships with international technology providers
• Government healthcare initiatives influencing medical technology standards and patient care requirements

Europe Market Split by Country

The Europe diabetes management software market is projected to grow from USD 785.0 million in 2025 to USD 2.4 billion by 2035, registering a CAGR of 11.9% over the forecast period. Germany is expected to maintain its leadership position with a 29.8% market share in 2025, supported by its advanced healthcare infrastructure and major medical centers.

United Kingdom follows with a 25.2% share in 2025, driven by comprehensive NHS digital programs and healthcare innovation initiatives. France holds a 22.6% share through specialized healthcare applications and clinical innovation requirements. Italy commands a 12.9% share, while Spain accounts for 7.1% in 2025. The Rest of Western Europe region is anticipated to gain momentum, expanding its collective share from 2.4% to 2.8% by 2035, attributed to increasing healthcare digitization investment in Nordic countries and emerging medical facilities implementing diabetes management advancement programs.

Cloud/SaaS Dominates Healthcare Applications in Germany

In Germany, the diabetes management software market prioritizes cloud/SaaS platforms, which capture the dominant 63% share of healthcare and clinical installations due to their advanced features, including precision scalability mechanisms and seamless integration with existing healthcare infrastructure. German healthcare operators emphasize effectiveness, security compliance, and long-term platform reliability, creating demand for cloud diabetes management systems that provide consistent patient care capabilities and adaptive performance based on clinical requirements and healthcare conditions. Other deployment types maintain secondary positions primarily in specialized applications and high-security facilities where comprehensive healthcare functionality meets clinical requirements without compromising data security effectiveness.

Market Characteristics:

• Premium focus on cloud/SaaS platforms with advanced scalability technology and precision healthcare capabilities
• Integration requirements with existing healthcare platforms and clinical management systems
• Emphasis on patient outcome optimization and long-term platform reliability in healthcare applications

Healthcare Technology Companies Lead Platform Development in United Kingdom

In United Kingdom, the market structure favors international healthcare technology companies, including Dexcom, Abbott, and Medtronic, which maintain dominant positions through comprehensive platform portfolios and established healthcare networks supporting both NHS and private diabetes management installations. These providers offer integrated solutions combining advanced diabetes software with professional clinical services and ongoing patient support that appeal to British healthcare providers seeking reliable diabetes care systems. Local healthcare contractors and digital health distributors capture a moderate market share by providing localized patient care capabilities and competitive pricing for standard platform installations, while domestic companies focus on specialized applications and premium solutions tailored to British healthcare characteristics.

Channel Insights:

• International healthcare technology brands maintaining premium market positioning through advanced platform offerings
• Local healthcare service networks expanding to support growing demand for professional clinical consultation and patient support
• Healthcare integration capabilities becoming a key differentiator for system-wide and clinical diabetes care applications

Competitive Landscape of the Diabetes Management Software Market

• Structure: ~20-25 credible players; top 3-5 hold ~50-55% by revenue.
• Leadership is maintained through: clinical validation, device integration, and patient engagement capabilities.
• What's commoditizing: basic data collection and standard reporting features.
• Margin Opportunities: AI-powered insights, clinical decision support, and integrated care platforms.

Stakeholder	What they actually control	Typical strengths	Typical blind spots
Medical device integrators	Device connectivity, clinical data, regulatory compliance	Hardware integration, clinical relationships	Software innovation; patient engagement
Digital health platforms	Software capabilities, user experience, data analytics	Technology innovation, patient engagement	Clinical validation; device integration
Healthcare system integrators	Provider relationships, clinical workflows, system integration	Healthcare integration, clinical adoption	Consumer engagement; platform innovation
Diabetes specialists	Clinical expertise, patient relationships, outcome focus	Clinical knowledge, patient trust	Technology development; scalability

Key Players in the Diabetes Management Software Market

• Dexcom
• Abbott
• Medtronic
• Roche
• Ascensia
• Glooko
• Tidepool
• OneDrop
• DarioHealth
• Tandem

Scope of the Report

Item	Value
Quantitative Units (2025)	USD 2.7 billion
Deployment	Cloud/SaaS, On-premise
Device Integration	CGM-linked, Insulin Pump-linked, Apps/Manual Entry
End User	Patients, Providers, Payers/Others
Application	Self-Management, Clinical Decision Support, Population Health Management, Remote Monitoring
Regions Covered	North America, Western Europe, East Asia, South Asia Pacific, Latin America, Middle East & Africa
Countries Covered	United States, Germany, United Kingdom, France, Japan, South Korea, Mexico, Canada, Italy, and 25+ additional countries
Key Companies Profiled	Dexcom, Abbott, Medtronic, Roche, Ascensia, Glooko, Tidepool, OneDrop, DarioHealth, Tandem
Additional Attributes	Dollar sales by deployment and device integration categories, regional adoption trends across North America, Western Europe, and East Asia, competitive landscape with healthcare technology manufacturers and digital health providers, healthcare provider preferences for clinical validation and patient engagement, integration with medical device platforms and healthcare systems, innovations in diabetes management technology and AI-powered analytics, and development of comprehensive care solutions with enhanced performance and patient optimization capabilities.

Diabetes Management Software Market by Segments

• Deployment:

  • Cloud/SaaS
  • On-premise

• Device Integration:

  • CGM-linked
  • Insulin Pump-linked
  • Apps/Manual Entry

• End User:

  • Patients
  • Providers
  • Payers/Others

• Application:

  • Self-Management
  • Clinical Decision Support
  • Population Health Management
  • Remote Monitoring

• Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Western Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Nordic
    • BENELUX
    • Rest of Western Europe
  • East Asia
    • China
    • Japan
    • South Korea
  • South Asia Pacific
    • India
    • ASEAN
    • Australia & New Zealand
    • Rest of South Asia Pacific
  • Latin America
    • Brazil
    • Chile
    • Rest of Latin America
  • Middle East & Africa
    • Kingdom of Saudi Arabia
    • Other GCC Countries
    • Turkey
    • South Africa
    • Other African Union
    • Rest of Middle East & Africa